AmgenvsMerck & Company

AMGN and MRK stock compared: price, dividend, valuation and results, from SEC filings.

AMGN

Amgen Inc.

$438.05

Value $236B

-1.32%
AMGN's page

MRK

Merck & Company, Inc.

$134.00

Value $331B

-2.74%
MRK's page

Amgen (AMGN) has a market value of $236B and Merck & Company (MRK) $331B. Over the last year, with dividends, AMGN moved +30.9% and MRK +43.1%. The P/E is 25.2 for AMGN and 135.1 for MRK. Dividend yield: AMGN 2.27%, MRK 2.54%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    AMGN$236B

    MRK$331B

    MRK is 1.4 times AMGN

  • Revenue, 12 months

    AMGN$38.9B

    MRK$67.4B

    MRK is 1.7 times AMGN

  • Net income, 12 months

    AMGN$9.4B

    MRK$2.5B

    AMGN is 3.8 times MRK

  • Operating margin

    AMGN32.4%

    MRK–

  • ROIC

    AMGN16.2%

    MRK3.9%

    12.3 points apart

  • P/E

    AMGN25.2

    MRK135.1

    MRK is 5.4 times AMGN

  • Dividend yield

    AMGN2.3%

    MRK2.5%

    0.2 points apart

  • 5-year return

    AMGN+148.8%

    MRK+87.9%

    60.9 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

AMGN+148.8%

MRK+87.9%

10015020025020222023202420252026
Returns by period
PeriodAMGNWith dividendsMRKWith dividends
1 year since November 18, 2025+30.9%Price +27.3%+43.1%Price +39.0%
3 years since November 17, 2023+79.2%+21.5% a yearPrice +65.1%+44.3%+13.0% a yearPrice +31.7%
5 years since November 18, 2021+148.8%+20.0% a yearPrice +114.7%+87.9%+13.5% a yearPrice +61.3%
10 years since November 21, 2016+302.6%+14.9% a yearPrice +201.0%+205.8%+11.8% a yearPrice +125.4%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

AMGNAmgenMRKMerck & Company

Valuation

AMGNMRK
Valuation
Price$438.05$134.00
Market value$236B$331B
Enterprise value (EV)$277B$375B
P/E25.2135.1
P/E, 5-year median23.014.8
P/B16.57.4
EV/EBIT22.078.8
Free cash flow yield4.1%4.5%

Results and growth

AMGNMRK
Results and growth
Revenue, 12 months$38.9B$67.4B
Net income, 12 months$9.4B$2.5B
Free cash flow, 12 months$9.6B$14.7B
Earnings per share, 12 months$17.25$0.98
Revenue growth, year on year10.0%1.3%
Revenue growth a year, past+7.6%over 5 years+9.4%over 5 years
EPS growth a year, past+2.9%over 5 years+21.2%over 5 years

Margins and returns on capital

AMGNMRK
Margins and returns on capital
Gross margin70.9%71.8%
Operating margin32.4%–
Net margin24.1%3.6%
ROIC16.2%3.9%
ROE87.8%5.2%

Balance sheet

AMGNMRK
Balance sheet
Cash$13.2B$9.7B
Total debt$54.0B$53.8B
Net debt / EBITDA2.35.7
Interest cover4.8×2.4×

Dividends and buybacks

AMGNMRK
Dividends and buybacks
Dividend yield2.3%2.5%
Dividend per share, 12 months$9.94$3.40
Dividend growth a year, past+8.1%over 5 years+5.8%over 5 years
Buyback yield–1.5%
Shareholder yield2.3%4.1%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: AMGN or MRK

Didn't find what you were looking for?

Ask us
Which is bigger, Amgen or Merck & Company?

By market value, Merck & Company ($331B) is about 1.4 times Amgen ($236B), at today's prices.

How did AMGN and MRK stock do over the last 10 years?

Since November 21, 2016, AMGN's price moved +201.0% and MRK's +125.4%. With dividends: AMGN +302.6% (+14.9% a year), MRK +205.8% (+11.8% a year). Past returns do not predict future ones.

Which pays the higher dividend, AMGN or MRK?

The dividend yield at today's price is 2.27% for Amgen and 2.54% for Merck & Company. Over the last twelve months they paid $9.94 and $3.40 per share.

What is the P/E of AMGN and MRK?

At today's price, the P/E is 25.2 for AMGN and 135.1 for MRK. The median of the last five years was 23.0 and 14.8, which shows where each stands against its own past.

Which has the higher profit margins, Amgen or Merck & Company?

Over the last twelve months, the net margin was 24.1% for Amgen and 3.6% for Merck & Company, and the operating margin 32.4% and –. Revenue was $38.9B and $67.4B.

Which is the better investment, Amgen or Merck & Company?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.